Time to separate MOG-Ab-associated disease from AQP4-Ab-positive neuromyelitis optica spectrum disorder

Eitemau Tebyg

• Characterizing mortality in patients with AQP4‐Ab + neuromyelitis optica spectrum disorder
  gan: Francis, A, et al.
  Cyhoeddwyd: (2024)
• The influence of smoking on the pattern of disability and relapse risk in AQP4-positive Neuromyelitis Optica Spectrum Disorder, MOG-Ab Disease and Multiple Sclerosis
  gan: Messina, S, et al.
  Cyhoeddwyd: (2021)
• Anti-MOG Antibodies in Japanese Patients with Neuromyelitis Optica Spectrum Disorders
  gan: Sato, D, et al.
  Cyhoeddwyd: (2014)
• Frequency of Aqp4-Ab in patients with neuromyelitis optica (Devic's syndrome) is higher than predicted by NMO-IgG testing
  gan: Jarius, S, et al.
  Cyhoeddwyd: (2007)
• Eculizumab in aquaporin-4-positive neuromyelitis optica spectrum disorder.
  gan: Pittock, S, et al.
  Cyhoeddwyd: (2019)